Virgin Pulse Expands Homebase for Health™ With Recent Addition of 16 Health and Wellbeing Partners

NEXT STORY
Mereo BioPharma and Ultragenyx Announce Collaboration and License Agreement for Setrusumab in Osteogenesis Imperfecta
PREV STORY
Vir Biotechnology and GSK Announce Start of NIH-Sponsored ACTIV-3 Trial Evaluating VIR-7831 in Hospitalized Adults with COVID-19
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Arcturus Therapeutics Executes Definitive Supply Agreement with the Israeli Ministry of Health

author_avatar
NASDAQ Market News

Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

author_avatar
NASDAQ Market News

OV – Oncology Venture receives authority clearance to expand an ongoing Phase 2 study of LiPlaCis by inclusion of prostate cancer patients

Hoersholm, Denmark, October 4, 2018 - Oncology Venture A/S (Nasdaq First North Stockholm: OV.ST) ...

author_avatar
NASDAQ Market News